lobbying_activities: 1296148
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1296148 | 0bc1dd46-4989-4d05-b8c1-75f794f0c933 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2012 | third_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2012-10-09T15:52:28.043000-04:00 |